Latest Insider Transactions at Vertex Pharmaceuticals Inc (VRTX)
This section provides a real-time view of insider transactions for Vertex Pharmaceuticals Inc (VRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VERTEX PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VERTEX PHARMACEUTICALS INC 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2020
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
7
-0.01%
|
$1,561
$223.29 P/Share
|
|
Nov 16
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct |
91
-0.11%
|
$20,293
$223.51 P/Share
|
|
Nov 16
2020
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Open market or private sale
|
Direct |
42
-0.04%
|
$9,366
$223.57 P/Share
|
|
Nov 10
2020
|
Bruce I Sachs Director |
BUY
Open market or private purchase
|
Direct |
15,000
+18.83%
|
$3,255,000
$217.58 P/Share
|
|
Nov 04
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
SELL
Open market or private sale
|
Direct |
2,330
-1.65%
|
$507,940
$218.47 P/Share
|
|
Nov 04
2020
|
Michael Parini EVP, Chief Adm, Leg & BD Off |
BUY
Exercise of conversion of derivative security
|
Direct |
2,330
+7.4%
|
$200,380
$86.52 P/Share
|
|
Nov 03
2020
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
1,553
-1.07%
|
$329,236
$212.15 P/Share
|
|
Nov 03
2020
|
Stuart A Arbuckle EVP, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,553
+4.06%
|
$133,558
$86.52 P/Share
|
|
Oct 05
2020
|
Sangeeta N. Bhatia Director |
SELL
Open market or private sale
|
Direct |
10,516
-16.07%
|
$2,786,740
$265.69 P/Share
|
|
Oct 05
2020
|
Sangeeta N. Bhatia Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,729
+37.7%
|
$1,099,854
$126.68 P/Share
|